beta-thujaplicin has been researched along with Leukemia in 1 studies
beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Falcone, ER | 1 |
| Holstein, SA | 1 |
| Anderson, AC | 1 |
| Wright, DL | 1 |
| Wiemer, AJ | 1 |
1 other study available for beta-thujaplicin and Leukemia
| Article | Year |
|---|---|
Novel α-substituted tropolones promote potent and selective caspase-dependent leukemia cell apoptosis.
Topics: Acetylation; Amino Acid Chloromethyl Ketones; Apoptosis; Caspases; Cell Line; Cell Proliferation; Ce | 2016 |